Roche Diagnostics

News

AI health tech Respiree closes $11.6m Series A

Health tech Respiree, developer of AI platforms to manage disease progression, has announced the successful closing of an $11.6m Series A financing.

News

FDA clears Roche self-collection system for HPV screening

The US FDA has approved a human papillomavirus (HPV) self-sampling solution developed by Roche that allows patients to collect a sample themselves in a healthcare setting.

Views & Analysis

Roundup: Pharma news from HLTH 2022

Although originally focused more on providers and health tech, the US conference HLTH has been steadily widening its scope and now hosts a wide variety of healthcare stakeholders.

News

Roche debuts smart glucose monitor for hospital use

Roche has launched what it says is a first-of-its-kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliv

News

Roche expands COVID testing portfolio with $1.8bn GenMark de...

Roche has said it will pay $1.8 billion for molecular testing company GenMark, boosting the Swiss company’s diagnostic capabilities and adding rapid COVID tests to its pandemic arsenal.

News